Loading clinical trials...
Loading clinical trials...
A Prospective Analysis Correlating the Osteoarthritic Knee Microenvironment to Clinical Outcome After Treatment With Regenexx® SD Treatment: A Multi-Site Study
Conditions
Interventions
Bone Marrow Concentrate treatment
Locations
3
United States
Interventional Orthopedics of Atlanta
Atlanta, Georgia, United States
Regenexx Des Moines
Des Moines, Iowa, United States
Regenexx Las Vegas
Las Vegas, Nevada, United States
Start Date
March 21, 2019
Primary Completion Date
October 30, 2020
Completion Date
March 30, 2022
Last Updated
September 28, 2023
NCT06755697
NCT07225829
NCT07351968
NCT06747494
NCT07036003
NCT06906939
Lead Sponsor
Regenexx, LLC
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions